Keywords
Sclerotherapy
Hydrocele
How to Cite
Abstract
Hydrocelectomy remains the most common treatment modality in the management of idiopathic hydrocoele. Aspiration and Sclerotherapy for hydroceles has gained increasing acceptance owing to its less-invasiveness and improved treatment outcomes almost par with surgery.
Objective: This study demonstrated the use of 10% Povidone Iodine for sclerotherapy as a safe and effective treatment option in the management of idiopathic hydroceles in adults.
Methods: This study was quasi-experimental in nature. Non-septated idiopathic hydroceles diagnosed at Vicente Sotto Memorial Medical Center Uro- OPD from October 1, 2014 - September 30, 2015, underwent hydrocele aspiration and sclerotherapy with 10% Povidone Iodine. Follow-up data were collected at 1, 4 and 8 weeks respectively. Patients with noted decrease in scrotal size, improved physical symptoms and minimal persistence (<30cc) of hydrocele fluid per scrotal ultrasound at 8 weeks were regarded as successful cases.
Results: A total of 20 patients presenting with 24 hydroceles underwent Aspiration and Scleroptherapy with Povidone Iodine. Twenty-one (87.5%) were successfully treated after a single procedure, and 3 (12.5%) eventually had hydrocelectomy. Mean aspirate volume of the success group is 249 cc versus 710 cc in the failure group. All of the patients reported no experience of pain/ discomfort during and immediately after the procedure. One patient followed up with a hematoma which spontaneously resolved at the 4th day post procedure.
Conclusion: The use of 10% Povidone Iodine is effective and safe sclerosing agent for aspiration and sclerotherapy of Idiopathic hydrocoeles. We report a success rate of 87% thus, using Povidone Iodine sclerotherapy for idiopathic hydroceles can be a practical, effective, safe and minimally invasive treatment alternative.